1. Home
  2. REPL vs AEHR Comparison

REPL vs AEHR Comparison

Compare REPL & AEHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • REPL
  • AEHR
  • Stock Information
  • Founded
  • REPL 2015
  • AEHR 1977
  • Country
  • REPL United States
  • AEHR United States
  • Employees
  • REPL N/A
  • AEHR N/A
  • Industry
  • REPL Biotechnology: Pharmaceutical Preparations
  • AEHR Electrical Products
  • Sector
  • REPL Health Care
  • AEHR Industrials
  • Exchange
  • REPL Nasdaq
  • AEHR Nasdaq
  • Market Cap
  • REPL 547.0M
  • AEHR 543.9M
  • IPO Year
  • REPL 2018
  • AEHR 1997
  • Fundamental
  • Price
  • REPL $5.71
  • AEHR $28.33
  • Analyst Decision
  • REPL Hold
  • AEHR
  • Analyst Count
  • REPL 9
  • AEHR 0
  • Target Price
  • REPL $7.00
  • AEHR N/A
  • AVG Volume (30 Days)
  • REPL 2.1M
  • AEHR 2.0M
  • Earning Date
  • REPL 11-11-2025
  • AEHR 10-09-2025
  • Dividend Yield
  • REPL N/A
  • AEHR N/A
  • EPS Growth
  • REPL N/A
  • AEHR N/A
  • EPS
  • REPL N/A
  • AEHR N/A
  • Revenue
  • REPL N/A
  • AEHR $58,968,000.00
  • Revenue This Year
  • REPL N/A
  • AEHR $6.19
  • Revenue Next Year
  • REPL $408.25
  • AEHR $33.87
  • P/E Ratio
  • REPL N/A
  • AEHR N/A
  • Revenue Growth
  • REPL N/A
  • AEHR N/A
  • 52 Week Low
  • REPL $2.68
  • AEHR $6.27
  • 52 Week High
  • REPL $17.00
  • AEHR $29.25
  • Technical
  • Relative Strength Index (RSI)
  • REPL 46.92
  • AEHR 66.37
  • Support Level
  • REPL $5.60
  • AEHR $25.59
  • Resistance Level
  • REPL $6.15
  • AEHR $28.41
  • Average True Range (ATR)
  • REPL 0.33
  • AEHR 2.15
  • MACD
  • REPL 0.06
  • AEHR 0.12
  • Stochastic Oscillator
  • REPL 32.48
  • AEHR 85.56

About REPL Replimune Group Inc.

Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.

About AEHR Aehr Test Systems

Aehr Test Systems is engaged in test systems for burning-in and testing logic, optical, and memory integrated circuits. Increased quality and reliability needs of the Automotive and Mobility integrated circuit markets. The Company operates in one business segment, the designing, manufacturing, marketing and selling of advanced test and burn-in products to the semiconductor manufacturing industry in several geographic areas. The company provides production solutions across the product manufacturing flow to improve yield and reliability and has developed and introduced several inventive products, including the ABTSTM and FOX-PTM families of test and burn-in systems and FOX WaferPakTM Aligner, FOX-XP WaferPak Contactor, FOX DiePak Carrier and FOX DiePak Loader.

Share on Social Networks: